Navamedic ASA (NAVA) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.072x

Based on the latest financial reports, Navamedic ASA (NAVA) has a cash flow conversion efficiency ratio of 0.072x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr24.19 Million ≈ $2.55 Million USD) by net assets (Nkr334.08 Million ≈ $35.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Navamedic ASA - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Navamedic ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NAVA current and long-term liabilities for a breakdown of total debt and financial obligations.

Navamedic ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Navamedic ASA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Vection Technologies Ltd
AU:VR1
0.003x
Pan Brothers Tbk
JK:PBRX
0.059x
Fractal Gaming Group AB
ST:FRACTL
-0.074x
Australian Vanadium Ltd
AU:AVL
-0.040x
Union Corporation
KO:000910
0.034x
Mawana Sugars Limited
NSE:MAWANASUG
0.961x
Francotyp-Postalia Holding AG
F:FPH
0.005x
Victory Square Technologies Inc
F:6F6
0.006x

Annual Cash Flow Conversion Efficiency for Navamedic ASA (2003–2025)

The table below shows the annual cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Navamedic ASA market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr334.08 Million
≈ $35.15 Million
Nkr25.59 Million
≈ $2.69 Million
0.077x -53.21%
2024-12-31 Nkr240.44 Million
≈ $25.30 Million
Nkr39.35 Million
≈ $4.14 Million
0.164x +1570.51%
2023-12-31 Nkr222.39 Million
≈ $23.40 Million
Nkr2.18 Million
≈ $229.29K
0.010x -88.55%
2022-12-31 Nkr209.72 Million
≈ $22.07 Million
Nkr17.94 Million
≈ $1.89 Million
0.086x +1095.23%
2021-12-31 Nkr151.24 Million
≈ $15.91 Million
Nkr-1.30 Million
≈ $-136.80K
-0.009x +65.00%
2020-12-31 Nkr129.49 Million
≈ $13.63 Million
Nkr-3.18 Million
≈ $-334.63K
-0.025x -115.29%
2019-12-31 Nkr79.23 Million
≈ $8.34 Million
Nkr12.72 Million
≈ $1.34 Million
0.161x +144.27%
2018-12-31 Nkr99.32 Million
≈ $10.45 Million
Nkr-36.02 Million
≈ $-3.79 Million
-0.363x -159.37%
2017-12-31 Nkr96.70 Million
≈ $10.18 Million
Nkr59.07 Million
≈ $6.22 Million
0.611x +545.20%
2016-12-31 Nkr105.73 Million
≈ $11.13 Million
Nkr-14.51 Million
≈ $-1.53 Million
-0.137x -171.72%
2015-12-31 Nkr118.28 Million
≈ $12.45 Million
Nkr22.63 Million
≈ $2.38 Million
0.191x +297.98%
2014-12-31 Nkr111.23 Million
≈ $11.70 Million
Nkr-10.75 Million
≈ $-1.13 Million
-0.097x +33.78%
2013-12-31 Nkr107.26 Million
≈ $11.29 Million
Nkr-15.65 Million
≈ $-1.65 Million
-0.146x -117.92%
2012-12-31 Nkr96.68 Million
≈ $10.17 Million
Nkr-6.47 Million
≈ $-681.19K
-0.067x -6435.86%
2011-12-31 Nkr93.24 Million
≈ $9.81 Million
Nkr-95.52K
≈ $-10.05K
-0.001x +99.24%
2010-12-31 Nkr100.21 Million
≈ $10.54 Million
Nkr-13.46 Million
≈ $-1.42 Million
-0.134x -811.95%
2009-12-31 Nkr111.78 Million
≈ $11.76 Million
Nkr-1.65 Million
≈ $-173.31K
-0.015x +84.76%
2008-12-31 Nkr110.24 Million
≈ $11.60 Million
Nkr-10.66 Million
≈ $-1.12 Million
-0.097x -324.44%
2007-12-31 Nkr128.99 Million
≈ $13.57 Million
Nkr5.56 Million
≈ $584.83K
0.043x +124.42%
2006-12-31 Nkr60.87 Million
≈ $6.40 Million
Nkr-10.74 Million
≈ $-1.13 Million
-0.176x -144.73%
2005-12-31 Nkr43.19 Million
≈ $4.54 Million
Nkr-3.11 Million
≈ $-327.70K
-0.072x +62.10%
2004-12-31 Nkr19.03 Million
≈ $2.00 Million
Nkr-3.62 Million
≈ $-381.04K
-0.190x +68.79%
2003-12-31 Nkr7.21 Million
≈ $758.70K
Nkr-4.40 Million
≈ $-462.53K
-0.610x --

About Navamedic ASA

OL:NAVA Norway Medical Distribution
Market Cap
$47.82 Million
Nkr454.45 Million NOK
Market Cap Rank
#22062 Global
#204 in Norway
Share Price
Nkr18.95
Change (1 day)
-0.26%
52-Week Range
Nkr18.95 - Nkr26.40
All Time High
Nkr42.60
About

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more